Impact of changes in methadone treatment during the COVID-19 pandemic
Scope and impact of methadone take-home and telehealth practice changes during the COVID-19 pandemic
This study looks at how the COVID-19 pandemic changed the way people get methadone treatment for opioid use disorder, focusing on things like take-home doses and online appointments, to see how these changes have affected patient care and treatment success.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Friends Research Institute, INC. NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10877871 on NIH RePORTER |
What this research studies
This research investigates how the COVID-19 pandemic has altered the delivery of methadone treatment for opioid use disorder, particularly through expanded take-home doses and telehealth services. It aims to understand the effects of these changes on patient care and adherence to treatment. By analyzing data from Opioid Treatment Programs, the study will assess the implications of these new practices on patient outcomes and the overall effectiveness of methadone treatment during this public health crisis.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals receiving methadone treatment for opioid use disorder, particularly those affected by the changes in treatment delivery during the COVID-19 pandemic.
Not a fit: Patients who are not currently receiving methadone treatment or those who do not have opioid use disorder may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to methadone treatment and better patient outcomes for those with opioid use disorder.
How similar studies have performed: Other research has shown that telehealth and flexible treatment options can improve patient engagement and outcomes, suggesting that this approach may be effective.
Where this research is happening
Baltimore, United States
- Friends Research Institute, INC. — Baltimore, United States (Active)
Researchers
- Principal investigator: Gryczynski, Jan — Friends Research Institute, INC.
- Study coordinator: Gryczynski, Jan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.